x
ServiziMenu principaleHome
You are here: Home > Events > Past events > 2020 > POSTPONED: Residential Course - Clinical Oncology: H&N Cancers, Uveal Melanoma, Rare Skin Cancers
Print

POSTPONED: Residential Course - Clinical Oncology: H&N Cancers, Uveal Melanoma, Rare Skin Cancers

12 ESCO credits

06.07.2020  -  08.07.2020

Milan and Pavia, Italy

COURSES AND SEMINARS

Head and neck cancers

Important information

Due to the ongoing Coronavirus (COVID-19) crisis we have made the decision to postpone the Residential Course - Clinical Oncology: Head and Neck Cancers, Uveal Melanoma, Rare Skin Cancers. We will be in contact with more details about this as soon as they are confirmed.

We deeply regret having to take this decision but we feel that in the current climate we all need to do our part in trying to limit the diffusion of the virus as much as possible and this was the only decision possible considering your role in society as medical staff.

We apologize for any inconvenience caused but we think you’ll all agree that this solution was unavoidable.

Description

Scientific Coordinator: L. Licitra, IT


This residential course on head and neck cancers is aimed at an international audience of clinical oncologists interested in advancing their knowledge and skills in the clinical management of these tumors, within a multidisciplinary context.
“Networking” is the key to improving the quality of care for rare cancers, therefore the course is developed in the framework of EURACAN, the European Reference Network on rare adult solid cancers, with the aim of reinforcing the collaboration among oncologists from different countries who are already part of the network or willing to join in the near future.

LEARNING OBJECTIVES
- To provide an overview of current multidisciplinary state-of-the-art treatment of head and neck cancers
- To discuss relevant clinical cases on a multidisciplinary basis
- To establish connections for future distance clinical mentoring/tutoring/networking

 

The residential course on head and neck
cancers is an ESO - EURACAN joint initiative
 
Held in collaboration with   INT

Faculty

INVITED FACULTY
S. Alfieri, Fondazione IRCCS Istituto Nazionale Tumori, Milano, IT
M. Angi, Fondazione IRCCS Istituto Nazionale Tumori, Milano, IT
P. Bossi, Medical Oncology, University of Brescia, IT
P.G. Casali, Fondazione IRCCS Istituto Nazionale Tumori, Milano, IT
S. Cavalieri, Fondazione IRCCS Istituto Nazionale Tumori, Milano, IT
M.R. Fiore, CNAO Foudation, Pavia, IT
G. Gatta, Fondazione IRCCS Istituto Nazionale Tumori, Milano IT
F. Huguet, Hopital Tenon, Paris FR
A. Iacovelli, Fondazione IRCCS Istituto Nazionale Tumori, Milano, IT
L. Licitra, Fondazione IRCCS Istituto Nazionale Tumori, Milano, IT
L. Locati, Fondazione IRCCS Istituto Nazionale Tumori, Milano, IT
P. Morbini, Department of Pathology, University of Pavia, IT
E. Orlandi, Fondazione IRCCS Istituto Nazionale Tumori, Milano, IT
C. Piazza, Fondazione IRCCS Istituto Nazionale Tumori, Milano, IT
L. Preda, Istituto Europeo di Oncologia, Milano, IT
A. Schindler, Department of Clinical and Biomedical Sciences, University of Milan, IT
C. Simon, Université de Lausanne, CHUV Lausanne, CH
B. Vischioni, CNAO Foudation, Pavia, IT
A. Trama, Fondazione IRCCS Istituto Nazionale Tumori, Milano IT

General information

ORGANISING SECRETARIAT
European School of Oncology
Rare Tumours Programme
Marina Fregonese
email: mfregonese@eso.net
phone: +39 02 23902106

ACCREDITATION
Application for CME recognition will be submitted to the European Accreditation Council for Continuing Medical Education (EACCME).
EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA).
Information on the status of the application can be obtained from the organising secretariat.

OFFICIAL LANGUAGE
The official language will be English. No translation will be provided.

VENUE
The course will be held on 6 and 7 July, 2020 at

Fondazione IRCCS Istituto Nazionale Tumori
Room G
Via G. Venezian 1
Milan, IT



The third day of the course (July 8) will be held at CNAO Foundation - Strada Campeggi, 53 - Pavia.
Transfer from Istituto Nazionale Tumori to CNAO will be organized. Information about the transfer will be given during the course.

Application

PARTICIPANT'S PROFILE
• Medical degree
• Current involvement in clinical activities in oncology
• Fluency in English

Priority will be given to younger candidates and low/middle income countries.
Only applications with all required information and attachments will be considered.

THE ONLINE APPLICATION SYSTEM WILL OPEN SOON

Programme

6 July

Fondazione IRCCS Istituto Nazionale Tumori, Milan
INTRODUCTION
8:30   Registration
9:00   Introduction - The natural history and biology
L. Licitra, IT
9:45   Epidemiology
G. Gatta, IT
10:30   Imaging
L. Preda, IT
11:15   Pathology
P. Morbini, IT
12:00   The problems of rare cancers
P. Casali, IT
12:30   The EU initiatives
A. Trama, IT
    Lunch
ORAL CAVITY (OC) AND OROPHARYNGEAL CANCER (OPC)
14:00   Oral cavity
C. Simon, CH
15:00   HPV negative OPC
Speaker to be confirmed
15:50   HPV positive OPC
L. Licitra, IT
16:30   Transoral surgery in OPC
C. Piazza, IT

 7 July

Fondazione IRCCS Istituto Nazionale Tumori, Milan
CANCERS OF LARYNX AND HYPOPHARYNX
9:00   Radiation for larynx and hypopharynx
F. Huguet,
10:00   Endoscopic surgery for larynx and hypopharynx
C. Piazza, IT
11:00   Principles of organ preservation
L. Licitra, IT
12:00   Medical therapy of recurrent and metastatic disease
L. Locati, IT
    Lunch
14:00   Salvage surgery
C. Piazza, IT
14:30   Re-irradiation
F. Huguet
15:00   Supportive care and nutrition in the curative setting
S. Alfieri, IT
16:00   Rehabilitation
A. Schindler, IT

 8 July

CNAO Foundation, Pavia
RARE CANCERS OF THE HEAD AND NECK
9:00   Nasopharyngeal cancer
E. Orlandi, IT
10:00   Radiation therapy in nasal, paranasal and salivary gland c
A. Iacovelli, IT
11:00   Hadron therapy in nasal, paranasal and salivary gland c
B. Vischioni, IT
12:00   Nasal cavity and paranasal sinus cancers
P. Bossi, IT
    Lunch
14:00   Uveal melanoma
M. Angi, IT
15:00   Hadron therapy in uveal melanoma
M.R. Fiore, IT
16:00   Rare skin cancers
S. Cavalieri, IT

Follow us